891787.fig.002
Figure 2: Focal nodular hyperplasia in gadolinium-enhanced MRI (contrast medium: gadoxetic acid; disodium salt (Primovist, Eurokontrast GmbH, Heidelberg), scanner: GE Signa HDxt 1,5T (General Electric Company, USA)): inhomogeneous hyperintensity on T1 FS in portal-venous contrast phase (T1 FSPGR FS FA12, TR 4,24 TE 2,04, TI 7).